These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 32483466)

  • 1. Depletion of the diabetic gut microbiota resistance enhances stem cells therapy in type 1 diabetes mellitus.
    Lv W; Graves DT; He L; Shi Y; Deng X; Zhao Y; Dong X; Ren Y; Liu X; Xiao E; Zhang Y
    Theranostics; 2020; 10(14):6500-6516. PubMed ID: 32483466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of Gut Microbiota by Low Methoxyl Pectin Attenuates Type 1 Diabetes in Non-obese Diabetic Mice.
    Wu C; Pan LL; Niu W; Fang X; Liang W; Li J; Li H; Pan X; Chen W; Zhang H; Lakey JRT; Agerberth B; de Vos P; Sun J
    Front Immunol; 2019; 10():1733. PubMed ID: 31417546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controls of Hyperglycemia Improves Dysregulated Microbiota in Diabetic Mice.
    Cao M; Peng Y; Lu Y; Zou Z; Chen J; Bottino R; Knoll M; Zhang H; Lin S; Pu Z; Sun L; Fang Z; Qiu C; Dai Y; Cai Z; Mou L
    Transplantation; 2021 Sep; 105(9):1980-1988. PubMed ID: 34416751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulated intestinal microbiota and gut immunity to ameliorate type 1 diabetes mellitus: A novel mechanism for stem cell-based therapy.
    Zheng SJ; Luo Y; Wang JB; Chen XM; Xu Y; Xiao JH
    Biomed Pharmacother; 2024 Jan; 170():116033. PubMed ID: 38128181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridial Butyrate Biosynthesis Enzymes Are Significantly Depleted in the Gut Microbiota of Nonobese Diabetic Mice.
    Tanca A; Palomba A; Fraumene C; Manghina V; Silverman M; Uzzau S
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30355671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cinnamaldehyde Improves Metabolic Functions in Streptozotocin-Induced Diabetic Mice by Regulating Gut Microbiota.
    Zhao H; Wu H; Duan M; Liu R; Zhu Q; Zhang K; Wang L
    Drug Des Devel Ther; 2021; 15():2339-2355. PubMed ID: 34103897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The delayed effects of antibiotics in type 2 diabetes, friend or foe?
    Fu L; Qiu Y; Shen L; Cui C; Wang S; Wang S; Xie Y; Zhao X; Gao X; Ning G; Nie A; Gu Y
    J Endocrinol; 2018 Aug; 238(2):137-149. PubMed ID: 29929986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of fecal microbiota transplantation on type 1 diabetes mellitus in non-obese diabetic mice and its underlying mechanism].
    Zhou Y; Li YY; Liu Y
    Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(16):1224-1231. PubMed ID: 35462505
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of gut microbiota in adult patients with type 1 and type 2 diabetes based on next‑generation sequencing of the 16S rRNA gene fragment.
    Salamon D; Sroka-Oleksiak A; Kapusta P; Szopa M; Mrozińska S; Ludwig-Słomczyńska AH; Wołkow PP; Bulanda M; Klupa T; Małecki MT; Gosiewski T
    Pol Arch Intern Med; 2018 Jun; 128(6):336-343. PubMed ID: 29657308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota.
    Deng L; Yang Y; Xu G
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Dec; 1867(12):159234. PubMed ID: 36185030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral insulin does not alter gut microbiota composition of NOD mice.
    Kihl P; Krych L; Buschard K; Wesley JD; Kot W; Hansen AK; Nielsen DS; von Herrath MG
    Diabetes Metab Res Rev; 2018 Sep; 34(6):e3010. PubMed ID: 29637693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prolonged antibiotic treatment induces a diabetogenic intestinal microbiome that accelerates diabetes in NOD mice.
    Brown K; Godovannyi A; Ma C; Zhang Y; Ahmadi-Vand Z; Dai C; Gorzelak MA; Chan Y; Chan JM; Lochner A; Dutz JP; Vallance BA; Gibson DL
    ISME J; 2016 Feb; 10(2):321-32. PubMed ID: 26274050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes.
    Zhang W; Ling Q; Wang B; Wang K; Pang J; Lu J; Bi Y; Zhu D
    Stem Cell Res Ther; 2022 Aug; 13(1):406. PubMed ID: 35941696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Edgeworthia gardneri (Wall.) Meisn. water extract improves diabetes and modulates gut microbiota.
    Zhang Z; Xu H; Zhao H; Geng Y; Ren Y; Guo L; Shi J; Xu Z
    J Ethnopharmacol; 2019 Jul; 239():111854. PubMed ID: 30954614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus.
    Lakshmanan AP; Shatat IF; Zaidan S; Jacob S; Bangarusamy DK; Al-Abduljabbar S; Al-Khalaf F; Petroviski G; Terranegra A
    Biomed Pharmacother; 2021 Aug; 140():111736. PubMed ID: 34034069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bidirectional association between the gut microbiota and CNS disease in a biphasic murine model of multiple sclerosis.
    Colpitts SL; Kasper EJ; Keever A; Liljenberg C; Kirby T; Magori K; Kasper LH; Ochoa-Repáraz J
    Gut Microbes; 2017 Nov; 8(6):561-573. PubMed ID: 28708466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
    Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
    Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics in early life alter the gut microbiome and increase disease incidence in a spontaneous mouse model of autoimmune insulin-dependent diabetes.
    Candon S; Perez-Arroyo A; Marquet C; Valette F; Foray AP; Pelletier B; Milani C; Ventura M; Bach JF; Chatenoud L
    PLoS One; 2015; 10(5):e0125448. PubMed ID: 25970503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats.
    Zhang M; Feng R; Yang M; Qian C; Wang Z; Liu W; Ma J
    BMJ Open Diabetes Res Care; 2019; 7(1):e000717. PubMed ID: 31641523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rb1 protects against diabetes-associated metabolic disorders in Kkay mice by reshaping gut microbiota and fecal metabolic profiles.
    Zhou R; He D; Zhang H; Xie J; Zhang S; Tian X; Zeng H; Qin Y; Huang L
    J Ethnopharmacol; 2023 Mar; 303():115997. PubMed ID: 36509256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.